Literature DB >> 19758660

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.

Dragomir P Zubac1, Leif Bostad, Björn Kihl, Tomas Seidal, Tore Wentzel-Larsen, Svein A Haukaas.   

Abstract

PURPOSE: We evaluated possible associations among thrombospondin-1, p53 expression, microvessel density, cell proliferation index, nuclear grade, tumor stage and continuously coded tumor size in clear cell renal cell carcinoma. The value of thrombospondin-1 as a prognostic marker in clear cell renal cell carcinoma was examined.
MATERIALS AND METHODS: A total of 172 consecutive patients with clear cell renal cell carcinoma treated with radical nephrectomy were initially enrolled in the study. However, due to technical problems and lack of material 12 cases were excluded from analysis. A total of 68 patients (43%) died of renal cell carcinoma and 46 (29%) died of other diseases. Median followup for the surviving 42 patients (29%) was 13.8 years. The expression of thrombospondin-1, Ki-67 (proliferation index), p53 and microvessel density were analyzed without knowledge of the clinical outcome on formalin fixed, paraffin embedded tissues.
RESULTS: Low expression of thrombospondin-1 was significantly associated with advanced stage (p <0.001), high nuclear grade (p = 0.001), positive p53 status (p <0.001), high proliferation index (p = 0.001), high microvessel density (p = 0.036) and tumor progression (p = 0.006). On univariate analysis thrombospondin-1, microvessel density, proliferation index, p53 over expression, TNM stage, Fuhrman nuclear grade (p <0.001) and continuously coded tumor size (p = 0.002) had a significant impact on survival. Multivariate analysis revealed TNM stage, thrombospondin-1, p53, Ki-67 (proliferation index) and microvessel density were independent predictors of cancer specific survival.
CONCLUSIONS: Thrombospondin-1 expression is strongly associated with prognostic tumor features in clear cell renal cell carcinoma and is an independent prognostic factor for cancer specific survival. Our findings revealed a significant correlation among p53, proliferation index, microvessel density and thrombospondin-1 expression, and indicate that thrombospondin-1 may have an impact on angiogenesis, proliferation and tumor aggressiveness in clear cell renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758660     DOI: 10.1016/j.juro.2009.07.015

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

Review 1.  Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers.

Authors:  Sumanta Kumar Pal; Marcin Kortylewski; Hua Yu; Robert A Figlin
Journal:  Mol Cancer Ther       Date:  2010-11-15       Impact factor: 6.261

2.  Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.

Authors:  Z-G Shi; S-Q Li; Z-J Li; X-J Zhu; P Xu; G Liu
Journal:  Clin Transl Oncol       Date:  2014-07-16       Impact factor: 3.405

3.  ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Authors:  Laura Arias-González; Inmaculada Moreno-Gimeno; Antonio Rubio del Campo; Leticia Serrano-Oviedo; María Llanos Valero; Azucena Esparís-Ogando; Miguel Ángel de la Cruz-Morcillo; Pedro Melgar-Rojas; Jesús García-Cano; Francisco José Cimas; María José Ruiz Hidalgo; Alfonso Prado; Juan Luis Callejas-Valera; Syong Hyun Nam-Cha; José Miguel Giménez-Bachs; Antonio S Salinas-Sánchez; Atanasio Pandiella; Luis del Peso; Ricardo Sánchez-Prieto
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

4.  Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis.

Authors:  Bing Zhang; Hong Ji; Dongliang Yan; Shaoqing Liu; Benkang Shi
Journal:  Tumour Biol       Date:  2013-11-23

5.  Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1.

Authors:  Raquel Bienes-Martínez; Angel Ordóñez; Mónica Feijoo-Cuaresma; María Corral-Escariz; Gloria Mateo; Olga Stenina; Benilde Jiménez; María J Calzada
Journal:  Sci Rep       Date:  2012-11-09       Impact factor: 4.379

Review 6.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

7.  Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy.

Authors:  Dragomir P Zubac; Tore Wentzel-Larsen; Tomas Seidal; Leif Bostad
Journal:  BMC Urol       Date:  2010-12-03       Impact factor: 2.264

8.  Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances.

Authors:  Juchao Ren; Hainan Liu; Lei Yan; Sujian Tian; Dawei Li; Zhonghua Xu
Journal:  World J Surg Oncol       Date:  2011-12-02       Impact factor: 2.754

9.  Thrombospondin-1 and VEGF in inflammatory bowel disease.

Authors:  Canan Alkim; Damlanur Sakiz; Huseyin Alkim; Ayten Livaoglu; Tulin Kendir; Huseyin Demirsoy; Levent Erdem; Nihat Akbayir; Mehmet Sokmen
Journal:  Libyan J Med       Date:  2012-01-30       Impact factor: 1.657

10.  Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.

Authors:  Yasuyoshi Miyata; Shin-ichi Watanabe; Hiroshi Kanetake; Hideki Sakai
Journal:  BMC Cancer       Date:  2012-08-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.